Back | Next |
home / stock / sls / sls message board
Subject | By | Source | When |
---|---|---|---|
Might go to 3 or lower | harry crumb | investorshub | 03/08/2022 3:32:03 PM |
IDK. We plunged like 16% today. Sure hope | tknuncle | investorshub | 03/08/2022 5:00:39 AM |
Whats up with the low volumn plunge today? | harry crumb | investorshub | 03/07/2022 8:55:05 PM |
We had a nice close yesterday, up 18 | tknuncle | investorshub | 03/01/2022 9:01:35 AM |
I really didn't know to look for that. | tknuncle | investorshub | 02/16/2022 4:23:45 AM |
Could make many millionaires! Bio's are tricky plays, | harry crumb | investorshub | 02/16/2022 12:13:58 AM |
I'm on the same page as you harry | tknuncle | investorshub | 02/15/2022 5:34:58 PM |
This could be become the stock of the | harry crumb | investorshub | 02/15/2022 3:33:44 PM |
U to | harry crumb | investorshub | 02/14/2022 3:00:08 PM |
That's great advice and I do that with | tknuncle | investorshub | 02/11/2022 10:37:53 PM |
Always hold a core position you can afford | harry crumb | investorshub | 02/11/2022 8:42:55 PM |
It looks like you were absolutely correct. We | tknuncle | investorshub | 02/11/2022 1:28:20 AM |
U to. Patience! $$$ | harry crumb | investorshub | 01/28/2022 10:13:40 PM |
Wouldn't that be the cats meow :). I'd | tknuncle | investorshub | 01/28/2022 6:51:53 PM |
20's are possible in due time | harry crumb | investorshub | 01/28/2022 3:19:53 AM |
This easily bounces an goes back to 6/7 area | harry crumb | investorshub | 01/28/2022 3:18:54 AM |
We get wonderful news last night after market | tknuncle | investorshub | 01/27/2022 6:55:39 PM |
Did you all see the news this evening? | tknuncle | investorshub | 01/27/2022 5:10:40 AM |
Where is the bottom of SLS? I picked | tknuncle | investorshub | 01/24/2022 2:34:15 AM |
znewcar1: Does SLS hold$5 or $4? | znewcar1 | investorshangout | 01/12/2022 4:02:29 AM |
News, Short Squeeze, Breakout and More Instantly...
SELLAS Life Sciences Group Inc. Company Name:
SLS Stock Symbol:
NASDAQ Market:
Investors might want to bet on Galena Biopharma, Inc. (NASDAQ: SLS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in ...
- Announced Independent Data Monitoring Committee’s (IDMC) Recommendation to Continue the Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Without Modifications: IDMC to Reconvene in June - - Completed Enrollment in Phase 3 REGAL Study of Galinpepimut-S - ...
- The Company Filed IP Protection Related to the ASXL1 Mutation, a Highly Prevalent Gene Mutation in Myeloid Malignancies and Solid Tumors With Significant Market Potential – - 100% Overall Response Rate in Patients with ASXL1 Mutation in the SLS009 30mg BIW Cohort to Date, Al...